Striverdi Respimat Spray, Metered
Pricing Report NDC 0597-0192-61

Current NADAC: $65.94844 per GM · Effective Aug 19, 2026

Current Package Pricing Information

The current wholesale acquisition cost for Striverdi Respimat (NDC 0597-0192-61) is $65.94844 per GM. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Boehringer Ingelheim Pharmaceuticals, Inc., this medication is distributed in a 1 CARTRIDGE in 1 CARTON / 60 SPRAY, METERED in 1 CARTRIDGE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$65.94844
Per GM

Effective Date
Aug 19, 2026
Data Status
As of Sep 09, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
1 CARTRIDGE in 1 CARTON / 60 SPRAY, METERED in 1 CARTRIDGE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The NADAC was calculated based on package size.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2015, the NADAC wholesale price for (NDC ) has moved within a range of $37.48850 to $66.08402 per GM. Over this 11 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$37.4885 - $66.0840
Market Volatility
76.28% Variance
Latest Trend
0.15%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $65.94844 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jul 22, 2026 $66.04713 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jun 17, 2026 $66.08402 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
May 20, 2026 $66.00845 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Jan 01, 2026 $65.98534 GMC/I - Chain or Independent PharmacyCode 2, 5B - Brand
Jan 01, 2026 $65.98534 GMC/I - Chain or Independent PharmacyCode 3, 5B - Brand
Jan 01, 2026 $65.98534 GMC/I - Chain or Independent PharmacyCode 4, 5B - Brand
Dec 17, 2025 $64.06531 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Nov 19, 2025 $64.02784 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Oct 22, 2025 $64.00850 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Sep 17, 2025 $64.04576 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand
Aug 20, 2025 $64.08068 GMC/I - Chain or Independent PharmacyCode 1, 5B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 5: The NADAC was calculated based on package size.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026